Our study had several limitations: the haploinsufficient model reduced c-Kit across all c-Kit expressing cell types (not SMC-specific); the CAL model lacked lipid-driven inflammation seen in atherosclerosis; and lineage tracing was not performed to identify and quantify progenitor contributions. This evidence concerns the gene KIT and atherosclerosis.